This unique report from the Publisher provides information and analysis, including:
CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D
The report is available by geographic region, country, section, and can be customized to specific information needs and budget.
Some segments will start resemblingmodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
- Supplier Sales and Shares by Segment and Test
- Volume and Sales Segment Forecasts by Test
- Supplier Strategies and SWOT Analysis
- Instrumentation Pipeline
- Emerging Technologies
- Opportunities for New Analyzers and Consumables
- Market Challenges and Risks
CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D
The report is available by geographic region, country, section, and can be customized to specific information needs and budget.
Geographic Regions and Countries
Africa
Algeria, Egypt, Ghana, Kenya, Morocco, Nigeria, South AfricaAsia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, VietnamEurope
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, UkraineLatin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, VenezuelaMiddle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab EmiratesNorth America
Canada, Mexico, USARationale
During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying petition.Some segments will start resemblingmodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
